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Laser-assisted Optical Rotational Cell Analyzer (LORCA)
Rheology
Deformability
Background: To investigate changes in red blood cell (RBC) rheology over time in critically ill patients with sepsis
and their relationship with outcome.
Methods: In this prospective, non-interventional study, RBC rheology was assessed using the Laser-assisted
Optical Rotational Cell Analyzer in a convenience sample of intensive care unit (ICU) patients with (n = 64)
andwithout (n= 160) sepsis. Results were compared tomeasures in healthy volunteers (n= 20). RBC rheology
was also assessed on days 1 and 3 of the ICU stay in 32 of the non-septic and 19 of the septic patients. RBC
deformability was determined by the elongation index (EI) in relation to the shear stress (0.3 to 50 Pa) applied
to the RBC membrane. An aggregation index (AI) was assessed simultaneously with the same device.
Results: The ICU mortality rate of the septic patients was 31%. RBC deformability was already reduced in septic
patients at ICU admission, an effect that persisted during the study period and worsened in the non-survivors
for the large majority of shear stresses studied (e.g., EI for 50 Pa of shear stress was 0.527 ± 0.064 in non-
survivors vs. 0.566 ± 0.034 in survivors, p b 0.05). These changes were not observed in non-septic patients.
The AI was more elevated in septic than in non-septic patients at ICU admission, but had no prognostic value.
Conclusions: Alterations in RBC rheology, including reduced deformability and increased aggregation, occur early
in septic patients and reductions in RBC deformability over time are associated with a poor outcome.
© 2015 Elsevier Inc. All rights reserved.
Introduction
Sepsis and septic shock are leading causes of death in critically ill
patients (Kaukonen et al., 2014; Vincent et al., 2009). Sepsis is character-
ized by complex pathophysiologic alterations that result in circulatory
and cellular alterations. The contribution of microcirculatory alterations
to the development of multiple organ dysfunction has been highlighted
over the last few decades (De Backer et al., 2002; Edul et al., 2012) and
the persistence of these alterations in septic patients is associated with
increased morbidity (Trzeciak et al., 2007, 2008) and mortality (Sakr
et al., 2004; Top et al., 2011) rates. One factor that can affect the micro-
vasculature (i.e., vessels with a diameter less than 100 μm) is red blood
cell (RBC) rheology (Serroukh et al., 2012).
Impaired RBC rheology (reduced deformability and increased
aggregation) has been demonstrated in critically ill patients, especially
those with sepsis, already at ICU admission (Baskurt et al., 1998a;
Kempe et al., 2007; Moutzouri et al., 2007; Piagnerelli et al., 2003;
Reggiori et al., 2009), but the time course of these alterations has
not been reported. We hypothesized that changes in RBC rheology
impairment over time in septic states could be related to mortality.
We, therefore, compared RBC deformability and aggregation in septic
and non-septic patients and healthy volunteers. We then studied
changes in RBC deformability and aggregation in septic and non-septic
patients during the ﬁrst 3 days following ICU admission. Finally, we
evaluated the relationship between alterations in RBC rheology and
mortality in the septic population.
Patients and methods
Patient selection and study design
This prospective studywas conducted in the 34-bedmedico-surgical
department of intensive care of Erasme University Hospital after ap-
proval by thehospital ethics committee. Informed consentwas obtained
from each patient or their next of kin. We studied 64 septic patients
aged ≥18 years who were admitted to the ICU (convenience sample).
Exclusion criteria included pregnancy, RBC transfusion in the previous
72 h, acute bleeding that needed RBC transfusion, neutropenia due to
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chemotherapy, transfer from another hospital or ICU readmission,
treatment with iron or erythropoietin, brain death or end-of-life
(withdrawal process). Sepsis was identiﬁed using standard criteria as
the presence (probable or documented) of infection together with
evidence of a systemic inﬂammatory response (Levy et al., 2003).
We also used data (collected in an overlapping period of time) from
20 healthy volunteers of both sexes and from 160 non-septic patients
(with the same exclusion criteria as for the septic patients) (Reggiori
et al., 2009).
At ICU admissionwe recorded age, sex, primary ICU admission diag-
nosis, source of sepsis, and the Acute Physiology and Chronic Health
Evaluation (APACHE) II score (Knaus et al., 1985). The Sequential
Organ Failure Assessment (SOFA) score (Vincent et al., 1996) was
calculated daily. At admission, and on days 1 and 3 we recorded RBC,
white blood cell (WBC) and platelet counts, hematocrit (Hct), hemoglo-
bin concentration (Hb), mean corpuscular volume (MCV), mean corpus-
cular hemoglobin (MCH), mean corpuscular hemoglobin concentration
(MCHC), red cell distribution width (RDW), coagulation tests (activated
partial thromboplastin time [aPTT], prothrombin time [PT], international
normalized ratio [INR], D-dimer, ﬁbrinogen), C-reactive protein (CRP),
serumsodium, bloodurea concentration, creatinine, total bilirubin, lactate
dehydrogenase (LDH), lactate, and blood glucose.
Assessment of RBC rheology
On days 0 (ICU admission), 1 and 3 in the ICU, we collected a single
blood sample in an EDTA-containing tube (2.5 mL of blood in 0.06 mL
EDTA, 0.235 mol/L, Terumo, Venoject) to assess hemorheology.
Measurements of RBC deformability
RBC deformability was assessed using the Laser-assisted Optical
Rotational Cell Analyzer (LORCA, Mechatronics Instruments BV, AN
Zwaag, Netherlands). A suspension of RBCs was mixed with polyvinyl-
pyrrolidone 360 solution, an isotonic viscous medium (PVP, 4%; MW
360 kDa; viscosity 30 ± 2 mPa·s), to obtain a ﬁnal solution with a
constant Hct of 0.2%. Using a Couette system composed of a glass cup
and a preciselyﬁtting bob,with a gap of 0.36mmbetween the cylinders,
the liquid solutionwas sheared and illuminated by a laser beam in order
to obtain a diffraction pattern produced by the deformed cells.
This pattern, the cup rotational speed and the predetermined shear
stresses were analyzed. The elongation index (EI) is calculated as:
EI = (L−W) / (L + W), where L and W are, respectively, the length
and width of the diffraction pattern. The geometry of the diffraction
pattern is elliptical. It has been shown that, for a given shear stress,
the greater the RBC deformability, the higher the EI (Baskurt et al.,
1998b). At 37 °C, we obtained the shear stress–EI curves for 12 consec-
utive shear stresses because human RBC deformability reaches a plateau
at 50 Pascals (Pa): 0.3, 0.48, 0.76, 1.21, 1.93, 3.07, 4.89, 7.78, 12.3, 19.7,
30 and 50 Pa. Interassay variabilities for each shear stress were: 51,
8.2, 3.9, 2.4, 1.7, 1.6, 1.1, 1.3, 1.7, 1.2, 1.4, and 1.2%, respectively.
Measurements of RBC aggregation
We also used the LORCA ektacytometer to analyze RBC aggregation
(Dobbe et al., 2003; Hardeman et al., 2001; Johnson, 1989). One millili-
ter of whole blood, collected in EDTA-containing tubes, was used for the
aggregation analysis: it was placed directly in the LORCA glass and the
patient's data were entered into the computerized system. At 37 °C,
the aggregation process is reﬂected by a decrease in laser back-scatter
intensity (Isc) after the motor engine is stopped abruptly. The so-
called syllectogram is the curve obtained by plotting Isc versus time; it
is then possible to calculate the aggregation index (AI), which shows
the kinetics and amplitude of aggregation, and the threshold shear
rate, which is a measure of the tendency of aggregation (representing
the minimal shear rate needed to prevent RBC aggregation) (Dobbe
et al., 2003). The kinetics of aggregation are expressed by the aggrega-
tion half-time (t½) in seconds, which is the time to half-maximal aggre-
gation. Y at Isc min is the minimum shear rate needed to prevent
rouleaux formation and Y at Isc max is the shear rate needed to disrupt
the formed rouleaux (Dobbe et al., 2003).
Table 1
Demographic and laboratory characteristics of all patients at ICU admission.
Variable Normal values Volunteers (n = 20) Non-septic (n = 160) Septic (n = 64)
Age (years) 38 ± 10 56 ± 17a 60 ± 14a
Sex (M/F) 11/9 96/64 41/23
APACHE II score 11 [8–17] 18 [14–24]b
SOFA score at ICU admission 3 [2–6] 8 [4–11]b
WBC (103/mm3) 4.2–11.4 6.0 [5.3–7] 10.7 [8.4–14.4]a 12.4 [7.8–17.9]a
Neutrophils (%) 38–73.4 56.7 [50.3–62.3] 81.6 [71.5–87.8]a 87.8 [81–92.2]ab
Hct (%) 35.3–52.1 43.3 [39.4–45.2] 36.1 [30.9–40.9]a 31.9 [26.3–37.1]ab
Hb (g/dL) 11.8–17.6 14.7 [13.5–15.4] 12.1 [10.7–13.7]a 10.2 [8.5 – 12.2]ab
RBC (106/mm3) 3.8–5.9 4.8 [4.2–5.1] 3.8 [3.4–4.4]a 3.3 [2.7 – 3.8]ab
Reticulocytes (absolute value) 30–111 64 ± 21 63 ± 47
MCV (μm3) 80.8–99.2 89.7 [87.7–92.5] 93.7 [91.1–98.6]a 96.3 [91.8–99.2]a
MCH (pg) 26.4–34.2 30.6 [30.0–32.1] 32.0 [30.9–33.2]a 31.4 [30.3–33.1]
MCHC (g/dL) 32–35.4 34.3 [34.1–34.7] 33.9 [33.1– 34.6] 32.9 [32.1–33.7]ab
Platelets (103/mm3) 150–400 274 [236–313] 253 [178–294] 188 [118–277]ab
aPTT (s) 24–35 27.7 [25.6–28.6] 30.2 [26.3–40.4]a 36.7 [31.4–44.7]ab
PT (%) 70–130 99 ± 7 78 ± 22a 56 ± 23 ab
INR 1.0 [1.0–1.1] 1.1 [1.0–1.3]a 1.4 [1.2–1.7]ab
Fibrinogen (mg/dL) 160–400 285 [243–336] 295 [239–367]a 562 [338–747]ab
D-dimer (ng/mL) b400 110 [85–155] 700 [400–1928]a 3775 [2340–7590]ab
CRP (mg/dL) b0.07 0.4 [0.1–2.0] 17 [11–28]b
Creatinine (mg/dL) 0.7–1.2 0.8 [0.6–0.9] 1.2 [0.8–2.3]b
BUN (mmol/L) 5.4–14.3 11.4 [7.5–15.7] 18.6 [9.3–31.1]b
Total bilirubin (IU/L) b1.2 0.5 [0.4–0.8] 0.7 [0.5–2.1]b
LDH (IU/L) b240 178 [137–229] 227 [164–336]b
Na (mEq/L) 135–145 140 [138–142] 138 [133–140]b
Glucose (mg/dL) 70–100 139 [110–172] 136 [105–169]
Lactate (mmol/L) b1.7 1.3 [0.9–2.5] 2 [1.2–3.4]b
Data are presented as mean ± SD or median value (25th–75th interquartile ranges) or number (%). SOFA: sequential organ failure assessment; WBC: white blood cell count; Hb:
hemoglobin; Hct: hematocrit; RBC: red blood cell; MCV: mean corpuscular volume; MCH: mean corpuscular hemoglobin; MCHC: mean corpuscular hemoglobin concentration; aPTT:
activated partial thromboplastin time; PT: prothrombin time; INR: international normalized ratio; CRP: C-reactive protein; LDH: lactate dehydrogenase; BUN: blood urea nitrogen.
Statistically signiﬁcant difference: anon-septic/septic vs. volunteers, bseptic vs. non-septic.
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Statistical analysis. Data were analyzed using SigmaStat v 3.5 software
package (Systat Software Inc., San Jose, California, USA) and IBM SPSS
version 19 (SPSS Inc., Chicago, IL, US). Data are presented as mean ±
SD,median value (25th–75th interquartile ranges) or number (%) as ap-
propriate. Non-parametric testswere used for variables evaluated as not
normally distributed. Difference testing between groupswas performed
using the Kruskal–Wallis one-way analysis of variance, the t-test, the
Mann–Whitney test, the chi2 test and the Fisher exact test, as appropri-
ate. A Bonferroni correction was made for multiple comparisons. To
test for a signiﬁcant difference between two study groups, and within
each group during the study period, a linear mixed model procedure
was used. For this purpose, we considered group (survivors or non-
survivors), time (days: 0, 1 and 3) and group by time interactions as
ﬁxed effects and patients as a random effect. Each time point difference
between groups was compared in case of a signiﬁcant group effect
and/or of a signiﬁcant time by group interaction. Time point differences
were tested in case of a signiﬁcant time effect in each group. All tests
were two-tailed, and a p b 0.05 was considered statistically signiﬁcant.
Results
Patients
We studied 224 critically ill patients who were admitted to the ICU
(64 with and 160 without sepsis, Table 1). Of these patients, 51 (19
septic and 32 non-septic) were analyzed for the full three-day study
period (Table 2). Because the group of patients present on the third
day was smaller than the whole population present on ICU admission,
we analyzed whether these groups were comparable, using the demo-
graphic and laboratory data shown in Tables 1–3. There were no signif-
icant differences between the groups, except for a higher APACHE II
score on admission in the non-septic patients (18 ± 7 vs. 12 ± 7,
p b 0.05) and a higher hemoglobin concentration in the septic patients
(11.6 ± 3.1 g/dL vs. 10.1 ± 2.1 g/dL, p b 0.05), suggesting that the
patients still present on day 3 were representative of thewhole popula-
tion. Seven patients (22%) died during the ICU stay in the non-septic
group, as a result of withdrawal of life-sustaining therapy in all patients
except one who was diagnosed with brain death.
Septic patients (n = 19) included in the 3-day analysis were more
severely ill on admission than were non-septic patients (n = 32), as
reﬂected by higher severity scores (Table 2). RBC count and Hb concen-
tration on admission were signiﬁcantly lower in septic and non-septic
patients than in healthy volunteers. In septic patients, coagulation,
renal and hepatic functions were more markedly altered and CRP
concentrationswere higher than in non-septic patients (Table 2). As ex-
pected, non-surviving septic patients were more severely ill at admis-
sion than septic survivors, as demonstrated by higher APACHE II and
SOFA scores (Table 3). The coagulation proﬁle (PT and platelet count)
was more altered and lactate concentrations were signiﬁcantly higher
in non-survivors compared to survivors throughout the study period
(days 0, 1 and 3) (Table 3).
Red blood cell deformability
At admission to the ICU, septic patients had marked alterations in
RBC deformability compared to non-septic patients and to volunteers
(Fig. 1). The differences between septic and non-septic patients
persisted during the 3 days of the study (Fig. 2). Among the septic
patients, RBC deformability was reduced early in survivors and non-
survivors; however, it worsened over time more in the non-survivors
than in the survivors (Fig. 3). The differences between survivors and
non-survivors were observed for the large majority of shear stresses
studied (Fig. 4): for example, the EI for shear stress of 50 Pa on day 3
was less in non-survivors than in survivors (0.527 ± 0.064 vs.
0.566 ± 0.034, p b 0.05); the decrease in EI reached 10% for several
shear stresses. Such alterations were not observed in non-septic
patients (data not shown). At day 0, an EI of 0.3 was correlated with ﬁ-
brinogen concentration in the patients with sepsis (r = 0.67, p b 0.05).
Red blood cell aggregation
RBC aggregation, as reﬂected by AI values, was greater in septic than
in non-septic patients (Fig. 5). There were no signiﬁcant differences
in AI in survivors and non-survivors over the study period (Table 4).
However, Y values at Isc min and max were lower in non-survivors
compared to survivors and this difference was statistically signiﬁcant
on day 1 for Y at Isc min and on day 3 for Y at Isc max.
Discussion
Our study conﬁrms the presence of early decreases in RBC
deformability and increases in aggregation in septic patients.We report,
for the ﬁrst time, a continuous worsening of RBC deformability over
time, with a decrease in EI of up to 10% by day 3 in septic non-
Table 2
Demographic and laboratory data at admission for the volunteers and for the patientswho







Age, years 38 ± 9 57 ± 17 64 ± 11
Male/female 11/9 24/8 13/6
APACHE II score 18 ± 7 21 ± 8



















RBC (106/mm3) 4.7 ± 0.5 3.9 ± 0.7a 3.5 ± 0.6a
Hb (g/dL) 14.5 ± 1.4 12.3 ± 2.1a 11.6 ± 3.1a
Hct (%) 42.3 ± 3.9 40.0 ± 7.0a 33.5 ± 6.0a
MCV (μm3) 90.0 ± 3.0 96.1 ± 5.8a 95.2 ± 4.5a
MCH (pg) 30.8 ± 1.3 32.3 ± 2.1 31.3 ± 1.6a
MCHC (g/dL) 34.3 ± 0.6 33.7 ± 1.2 32.8 ± 0.3a
RDW (%) 11.6 ± 0.6 12.5 ± 1.2 14.0 ± 0a
Platelets (103/mm3) 289 ± 80 252 ± 97 232 ± 124
APTT (s) 28.1 ± 3.2 34.2 ± 12.7 38.5 ± 13.8a
PTT (s) 99 ± 7 78 ± 20a 53 ± 24a
INR 1.0 ± 0.04 1.2 ± 0.2 1.7 ± 1.0a
Fibrinogen (mg/dL) 304 ± 86 382 ± 147 600 ± 269a
WBC (103/mm3) 6.1 ± 1.6 12.1 ± 4.7a 12.9 ± 5.7a
BUN (mmol/L) NA 20.37 ± 13.78 39.95 ± 27b
Creatinine (mg/dL) NA 1.1 ± 1.0 2.1 ± 1.6b
Bilirubin (IU/L) NA 0.7 ± 0.5 2.1 ± 2.5b
Glucose (mg/dL) NA 157 ± 58 134 ± 39
CRP (mg/dL) NA 3.5 ± 4.7 20.6 ± 12.5b
Lactate (mmol/L) NA 2.6 ± 2.7 3.0 ± 2.5
Statistically signiﬁcant difference, aversus volunteers, bversus non-septic.
Data are presented as mean ± SD or median value (25th–75th interquartile ranges) or
number (%). SOFA: sequential organ failure assessment; WBC: white blood cell count;
Hb: hemoglobin; Hct: hematocrit; RBC: red blood cell; RDW: red cell distribution width;
MCV: mean corpuscular volume; MCH: mean corpuscular hemoglobin; MCHC: mean
corpuscular hemoglobin concentration; aPTT: activated partial thromboplastin time; PT:
prothrombin time; INR: international normalized ratio; CRP: C-reactive protein; LDH:
lactate dehydrogenase; BUN: blood urea nitrogen.
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survivors. By contrast, changes in RBC aggregation were not associated
with outcome.
Alterations in RBC deformability during sepsis have been reported in
animals and in humans (Baskurt et al., 1998a; Condon et al., 2007;
Piagnerelli et al., 2009; Reggiori et al., 2009; Spolarics et al., 2004). We
previously observed, using ﬂow cytometry, that the sphericity index,
which was used to assess RBC shape, increased rapidly during sepsis
(Piagnerelli et al., 2003), suggesting that during sepsis RBCs have a
more spherical shape, whichmay be associated with a reduced capacity
to deform. The ﬂow cytometry technique only provides information on
RBC shape, whereas the LORCA used in the present study allows the
dynamic study of RBC deformability in relation to the shear stresses
applied to the cell membrane. Using LORCA, Baskurt et al. (1998a) dem-
onstrated that EI values were signiﬁcantly lower in 10 septic patients
compared to healthy volunteers at shear stresses b5 Pa. In contrast,
using a cell ﬁltration system, they observed no change in RBC
deformability in the same cohort of patients, thus demonstrating the
high sensitivity of the LORCA device. Furthermore, using the same de-
vice, we recently reported that RBC deformability and aggregation
were altered early in critically ill patients (Reggiori et al., 2009), with
decreased deformability in septic patients compared to non-septic
patients and healthy volunteers, and increased aggregation in septic
patients compared to healthy volunteers. However, these studies inves-
tigated patients at one moment in time, without speciﬁc information
about the time delay from the onset of sepsis or about the time course
of these measurements.
In the present study, we observed a decrease in deformability with
time that reached up to 10% for several shear stresses. This decrease in
RBC deformability may impact on the microcirculation. In a rat model
of isolated perfused leg, Baskurt observed up to 78% increase in blood
ﬂow resistance after perfusion of RBCs with reduced deformability fol-
lowing incubation with glutaraldehyde (Baskurt, 2003). Interestingly,
the author reported that decreases in blood ﬂow appeared when the
percentage reduction in RBC deformability exceeded 7%. Cabrales
(2007), also using glutaraldehyde-treated RBCs, demonstrated in an
awake hamster model, a signiﬁcant reduction in functional capillary
density, arteriolar diameter and ﬂow, leading to a signiﬁcant reduction
in arteriolar, tissue, and venular oxygenation. Moreover, Simchon et al.
(1987) noted that rat RBCs with reduced deformability became
entrapped in the microvascular network of the spleen, lung, liver and
femur, thus reducing regional blood ﬂow. In a sepsis model using
cecal-ligation and puncture in rats, Bateman et al. (2001) reported
that reduced RBC deformability was associated with decreased
functional capillary density. All these studies, therefore, suggest the
Table 3
Demographic and laboratory characteristics of the septic patients during the study period.












Age, years 60 ± 14 60 ± 14 64 ± 11
Sex (M/F) 41/23 29/16 13/6
APACHE II score 18 ± 8 24 ± 9*
SOFA score 6 ± 4 10 ± 4* 6 ± 4 9 ± 4* 6 ± 5 8 ± 3*
WBC (103/mm3) 16.2 ± 14.9 13.5 ± 9.6 11.9 ± 5.5 15.8 ± 9.6 12.9 ± 7.2 17.2 ± 3.8
Neutrophils (%) 83 ± 16 88 ± 7 84 ± 9 83 ± 10 80 ± 9 81 ± 9
Hct (%) 31.6 ± 5.9 31.8 ± 7.2 32.0 ± 5.1 29.4 ± 5.2¿ 29.3 ± 5.8§ 28.1 ± 4.4μ
Hb (g/dL) 10.4 ± 2.1 10.9 ± 3.3 10.4 ± 1.7 9.5 ± 1.8¿ 9.6 ± 1.8 9.2 ± 1.4μ
RBC (106/mm3) 3.33 ± .67 3.21 ± 0.79 3.34 ± 0.53 2.97 ± 0.55¿ 3.09 ± 0.58§ 2.96 ± 0.47μ
Reticulocytes (absolute value) 19 ± 15 23 ± 5 19 ± 17 28 ± 14 15 ± 10 17 ± 14
MCV (μm3) 95 ± 6 99 ± 11* 96 ± 5# 99 ± 7*¿ 95 ± 6 95 ± 3
MCH (pg) 31.3 ± 2.2 32.7 ± 3.6 31.1 ± 2.1# 32.1 ± 2.2* 31.0 ± 1.9 30.9 ± 1.6
MCHC (g/dL) 32.9 ± 1.4 32.8 ± 1.1 32.4 ± 1.0# 32.4 ± 1.1 32.6 ± 1.0 32.6 ± 1.5
RDW (%) 14 ± 2.3 15.1 ± 3.4 13.4 ± 1.8# 15.2 ± 3.7 13.7 ± 2.0 14.9 ± 2.0μb
Platelets (103/mm3) 234 ± 142 161 ± 103* 214 ± 126# 147 ± 132* 186 ± 127§ 151 ± 818*
aPTT (s) 39.2 ± 14.3 43.1 ± 15.9 40.4 ± 15.4 54.2 ± 29.7 37.2 ± 9.7 56.4 ± 42.3
PT (%) 61 ± 21 46 ± 24* 68 ± 20 44 ± 21* 74 ± 18 47 ± 23*
INR 1.5 ± 0.9 1.9 ± 1.0 1.28 ± 0.23 2.16 ± 1.48 1.23 ± 0.32 1.95 ± 1.11
Fibrinogen (mg/dL) 619 ± 307 482 ± 275 663 ± 245# 484 ± 270 771 ± 325 372 ± 299
D-dimer (ng/mL) 4444 ± 2806 5373 ± 2091 4278 ± 2440 4308 ± 2779 3796 ± 1984¥ 2750 ± 1103
CRP (mg/dL) 19.3 ± 12.5 20.9 ± 15.5 22.2 ± 11.5# 20.4 ± 10.0 16.1 ± 8.7§ 17.8 ± 12.3
BUN (mg/dL) 29.4 ± 23.4 40.2 ± 27.6 27.6 ± 25.2 33.2 ± 17.8 32.2 ± 34.6 36.4 ± 20.6
Total bilirubin (mg/L) 1.5 ± 2.2 2.8 ± 2.9 1.2 ± 1.7 2.5 ± 3.0* 1.5 ± 2.4 3.8 ± 4.6*
LDH (IU/L) 343 ± 609 368 ± 208 362 ± 509 676 ± 958*¿ 353 ± 315 478 ± 334
Na (mEq/L) 137 ± 5 136 ± 6 139 ± 5# 139 ± 6 137 ± 4 139 ± 3
Glucose (mg/dL) 144 ± 52 130 ± 57 124 ± 41# 116 ± 41 110 ± 17 126 ± 44
Lactate (mmol/L) 2.2 ± 1.5 4.7 ± 4.1* 1.6 ± 1.1 4.4 ± 4.9* 1.4 ± 0.8 3.1 ± 3.2*
Data are presented as mean ± SD or median value (25th–75th interquartile ranges) or number (%). SOFA: sequential organ failure assessment; WBC: white blood cell count; Hb: hemo-
globin; Hct: hematocrit; RBC: red blood cell; MCV:mean corpuscular volume;MCH:mean corpuscular hemoglobin; MCHC:mean corpuscular hemoglobin concentration; aPTT: activated
partial thromboplastin time; PT: prothrombin time; INR: international normalized ratio; CRP: C-reactive protein; LDH: lactate dehydrogenase; BUN: blood urea nitrogen.
Statistically signiﬁcant difference: * = survivors vs. non-survivors, # = among survivors, day 1 vs. day 0, § = among survivors, day 3 vs. day 0, ¥= among survivors, day 3 vs. day 1, ¿ =
among non-survivors, day 1 vs. day 0, μ= among non-survivors, day 3 vs. day 0, b = among non-survivors, day 3 vs. day 1.
Fig. 1. RBC deformability as assessed by elongation index (EI) at different shear stresses in
septic and non-septic patients at admission and in healthy volunteers. *p b 0.05 sepsis vs.
volunteers; £: p b 0.05 sepsis vs. non-sepsis.
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existence of a link between reduced RBC deformability and impaired
microcirculation. Nevertheless, these data must be interpreted with
caution in view of the interspecies differences in RBC rheology
(Baskurt et al., 1997).
The alterations in RBC deformability observed during sepsis may
also depend on membrane component properties, cell geometry and
cytoplasmic viscosity. The cell membrane is fundamental not only for
cell integrity, but also for cell function. Indeed, membrane components
may be altered during sepsis, as has been reported especially for RBC
membrane sialic acid (SA) content (Piagnerelli et al., 2003), a surface
membrane carbohydrate, and lipids (Kempe et al., 2007; Poschl et al.,
2003). Reduced RBC deformability could be due to a persistent decrease
in SA membrane content during the evolution of sepsis. Indeed, in an
earlier study, we observed increased activity of neuraminidase, the
enzyme that cleaves the glycosidic linkages of neuraminic acids, such
as membrane SA, already at ICU admission (Piagnerelli et al., 2009).
The decrease in SA content could initially be beneﬁcial, because some
studies have shown that RBCs are able to recycle the free SA released
by neuraminidase (Bulai et al., 2002, 2003) through a cytosolic sialate
pyruvate-lyase that speciﬁcally and reversibly catalyzes the cleavage
of SA to form N-acetylmannosamine and pyruvate (Bulai et al., 2002,
2003). We have also observed that RBCs with decreased deformability
can modify their metabolism to increase 2,3-diphosphoglycerate
concentrations (Piagnerelli et al., 2009). This effect induces a change
in hemoglobin conformation with increased potential for oxygen
downloading to the cells. These adaptations in RBC metabolism could
be beneﬁcial at the onset of sepsis. The modiﬁcation of RBC membrane
Fig. 2. Elongation index (EI) at different shear stresses in septic and non-septic patients on
days 1 (panel A) and 3 (panel B). *p b 0.05.
Fig. 3. Change in elongation index (EI) in septic patients on day 3 compared to day 0 (∆EI)
at shear stress of 50 Pa (survivors: 0.008 ± 0.040; non-survivors: −0.027 ± 0.020)
*p b 0.05.
Fig. 4. Elongation index (EI) at different shear stresses in septic survivors and non-survivors
on day 3.
Fig. 5. RBC aggregation, as assessed by the aggregation index (AI), in septic and non-septic
patients at admission and in healthy volunteers. *p b 0.05 septic vs. non-septic.
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proteins is more controversial, as the increased integral/peripheral
protein ratio in RBCs found in mice (Condon et al., 2007) could not be
demonstrated to the same extent in human RBCs (Piagnerelli et al.,
2003, 2012). Finally, there is an important relationship between RBC
deformability, shear rate and blood viscosity. For shear rates b10 Pa,
viscosity of blood with hardened RBCs is higher than for blood with
more deformable RBCs (Somer and Meiselman, 1993). More rigid
RBCs may encounter difﬁculties in passing through small capillaries,
thus reducing peripheral oxygen delivery and inducing cellular hypoxia.
For aggregation as assessed by the AI, in contrast to the ﬁndings for
deformability, there were no signiﬁcant differences between septic
survivors and non-survivors. In our study, the threshold shear rate,
the force needed to disrupt RBC rouleaux formation, was higher in
septic than in non-septic patients and healthy volunteers. This ﬁnding
conﬁrms the tendency for multiple cell aggregates to form in the
blood of septic patients (Reggiori et al., 2009). We could speculate
that this may be related to the higher blood ﬁbrinogen concentrations
in septic compared to non-septic patients. Indeed, ﬁbrinogen is
necessary to form bridges between RBCs and facilitate aggregation.
Nevertheless, there was no correlation between aggregation (AI)
and ﬁbrinogen concentrations, unlike previous reports (Rogowski
et al., 2000), and the signiﬁcant correlation that we found between
deformability (EI) and ﬁbrinogen at day 0 disappeared with time.
The present study has some limitations. First, our results describe
the evolution over time of a small cohort of patients. Second, the tech-
nique used does not evaluate the relationship with other blood cells
(WBCs and platelets), whose role in the microcirculation could also be
important. Indeed, Baskurt and Meiselman demonstrated that RBC
deformability may be altered by activated WBCs via reactive oxygen
species (Baskurt and Meiselman, 1998). Third, we could not isolate
erythrocyte subpopulations, becausewedid not have access to a centrif-
ugal elutriation system (Condon et al., 2003). Fourth, we did not
perform concurrent microcirculatory measurements. Finally, we can
only speculate on the possible mechanisms underlying our ﬁndings
and further, mechanistic studies need to be performed to investigate
this aspect.
In conclusion, RBC aggregation is increased and deformability de-
creased early in critically ill septic patients. Reduced deformability over
time is associated with increased mortality. As altered RBC rheology
may contribute to the impaired microcirculation observed in septic
patients, further studies are warranted to investigate the evolution of
this determinant of oxygen delivery in sepsis. Indeed, a better under-
standing of the microcirculation in all its complexity during septic states
may lead to new therapeutic strategies to monitor and improve tissue
perfusion, so as to decrease the incidence of sepsis-associated multiple
organ failure and its associated high mortality rates.
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